UTEC (The University of Tokyo Edge Capital Partners)
Overview
UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo. They invest in deep-tech startups that solve global issues of humankind using science & technology, focusing on Healthcare & Life Sciences, IT/AI, and Physical Sciences & Engineering. UTEC provides hands-on support from the seed/early stages in cooperation with partners in academia in Japan and abroad.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| ALGO ARTIS Corporation | Jun 2026 | Series B | Co-investor |
| Oxford Quantum Circuits | Jun 2026 | Series C | Co-investor |
| Calaris Inc. | Jun 2026 | Seed | Lead |
| TriOrb Inc. | Jun 2026 | Series B | Co-investor |
| Violet Therapeutics | May 2026 | Seed | Co-investor |
Key People
Bruce Goldsmith
Venture Partner
Hirofumi Oki
Venture Partner, Senior Manager, HR Executive Talent
Kenichi Imahashi
Venture Partner
Lisa Paborsky
Venture Partner
Masafumi Asakura
Venture Partner
Tomohiko Okiyama
Venture Partner
関秀樹
Venture Partner
Maiko Katadae
Partner
MD/MBA Hiroaki Kobayashi
Partner
Noriaki Sakamoto
COO, Managing Director, Board Member Partner
Atsushi Usami
Partner And Board Director
Azusa Shiohara
Principal
Kiran Mysore
Principal
Takashi Miyahara
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
